27 August 2024 | 10:30-12:00

Format: Presentation
Stream: Populations

Part 1: Safe options and integration of alternative medicine

Session details coming soon.

Yi Bin Feng Hong Kong University, Hong Kong

 

Part 2: Development of a clinical guideline for Herb-drug co-use for Hospital Authority and beyond

The Integrated Chinese and Western Medicine (ICWM) programmes, initially known as ICWM Pilot Projects was commenced in HA hospitals since 2014. The safety of herb-drug co-use is crucial in the practice. In addition to a heightened assurance of herb safety, commercial herb-drug interaction databases from overseas were being subscripted to provide guidance for clinical practice. Despite the availability of several well known databases, gaps remained between their recommendations and real life practice. To address the problem, the Expert Panel on Herb Safety was formed to develop a clinical guideline for the integrative use of Chinese herbs and drugs. The panel consisted of experts from both Chinese medicine and western medicine fields. Systemic review were performed on the subject followed by risk assessment on individual herb for potential herb-drug interaction. Clinical recommendations were made according to the risk level of a herb assigned through consensus meetings. The resultant guideline consisted of the many recommendations made by the panel which is evidence-based, with a wide safety margin and being user-friendly. Further enhancement, updating and validation of the guideline is in progress with a vision to extend its use for ICWM practice outside HA.

Tse Man Li Hong Kong Poison Centre, Hong Kong

 

Part 3: How to complement Western Medicine with Traditional Chinese Medicine

Justine Wu Chinese University of Hong Kong Medical Centre